‘Ultra-Strength’ Cocaine Hits UK Streets as Deaths Surge to Record High
‘Ultra-Strength’ Cocaine Hits UK Streets as Deaths Surge to Record High

A lethal wave of ‘ultra-strength’ cocaine is spreading across the UK, with deaths linked to the drug reaching a record high, an investigation by The Independent has found. Experts attribute the surge in purity to a boom in cocaine production in South America, which has flooded the UK market with high-grade powder. Users are unknowingly taking greater risks, as street-level purity has risen sharply over the past decade.

Undercover testing at the Cheltenham Festival, attended by over 200,000 people this year, revealed that two out of three cocaine samples sent for analysis had a purity of 85 per cent. The samples were collected from toilet surfaces, including one from a baby changing facility. Dr Arija Durrant, a postdoctoral researcher at Kingston University who conducted the tests, warned of a heightened risk of overdose for users accustomed to lower-purity substances.

Former UK drugs tsar Mike Trace described the findings as ‘highly concerning’ and called for urgent government action. ‘Higher, unpredictable purity is the biggest risk factor,’ he said, noting that users expecting a certain effect from a lower-purity batch could be in danger. The NHS warns that cocaine use can cause heart attacks, strokes and seizures, with the risk amplified when mixed with alcohol.

Data shows cocaine-related deaths have risen for 13 consecutive years, increasing by 14 per cent from 1,118 in 2023 to 1,279 in 2024. Hospital admissions for cocaine and crack cocaine use tripled between 2007-08 and 2017-18. Among the victims was Lucy White, a criminology student who died from a cardiac arrest caused by the drug; her sister has called for improved education on the risks.

The National Crime Agency estimated average street-level purity at 32-38 per cent in 2013, but experts say it has since risen above 80 per cent. Peter Cain, a drug science adviser at Eurofins Forensic Services, noted that purity reached around 75 per cent during the pandemic and has continued to climb. The European Union Drugs Agency reported that average purity in half of its member states now ranges from 66 to 81 per cent, reflecting a buyer’s market with stronger product at lower prices.